Ann‐Marie Määttä
- Co-authors
- Seppo Ylä‐HerttualaJere T. PikkarainenHaritha SamaranayakeJarmo WahlforsRiikka PellinenAri HinkkanenHanna P. LeschKimmo Mäkinen
- Topics
- Virus-based gene therapy research (11 papers)Cancer Research and Treatments (4 papers)Herpesvirus Infections and Treatments (4 papers)
- Partner nations
- FinlandFranceUnited Kingdom
In The Last Decade
Ann‐Marie Määttä
20 papers receiving 397 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 255
- Genetics 216
- Oncology 85
- Biomedical Engineering 54
- Biotechnology 45
Countries citing papers authored by Ann‐Marie Määttä
This map shows the geographic impact of Ann‐Marie Määttä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann‐Marie Määttä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann‐Marie Määttä more than expected).
Fields of papers citing papers by Ann‐Marie Määttä
This network shows the impact of papers produced by Ann‐Marie Määttä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann‐Marie Määttä. The network helps show where Ann‐Marie Määttä may publish in the future.
Co-authorship network of co-authors of Ann‐Marie Määttä
This figure shows the co-authorship network connecting the top 25 collaborators of Ann‐Marie Määttä. A scholar is included among the top collaborators of Ann‐Marie Määttä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann‐Marie Määttä. Ann‐Marie Määttä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 19 | |
| 3 | 37 | |
| 4 | 17 | |
| 5 | 6 | |
| 6 | 43 | |
| 7 | 30 | |
| 8 | 16 | |
| 9 | 2 | |
| 10 | 19 | |
| 11 | 12 | |
| 12 | Clinical trials for glioblastoma multiforme using adenoviral vectors. | 19 |
| 13 | 38 | |
| 14 | 36 | |
| 15 | 40 | |
| 16 | 27 | |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 28 | |
| 20 | 33 |
About Ann‐Marie Määttä
Ann‐Marie Määttä is a scholar working on Biotechnology, Genetics and Cell Biology, having authored 20 papers that have together received 431 indexed citations. Recurring topics across this work include Virus-based gene therapy research (11 papers), Cancer Research and Treatments (4 papers) and Herpesvirus Infections and Treatments (4 papers). The work is most often cited by research in Genetics (216 citations), Biotechnology (45 citations) and Molecular Biology (255 citations). Ann‐Marie Määttä has collaborated with scholars based in Finland, France and United Kingdom. Frequent co-authors include Seppo Ylä‐Herttuala, Jere T. Pikkarainen, Haritha Samaranayake, Jarmo Wahlfors, Riikka Pellinen, Ari Hinkkanen, Hanna P. Lesch, Kimmo Mäkinen, Timo Liimatainen and Thomas Wirth. Their work appears in journals such as PLoS ONE, Cancer Research and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.